Aripiprazole

Overview

Aripiprazole is an atypical antipsychotic medication used primarily in the treatment of schizophrenia and bipolar disorder. It is notable for its unique mechanism of action that involves partial agonist activity at D2 dopamine and 5-HT1A serotonin receptors.

API suppliers (45)

Suppliers of Aripiprazole evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• INTERQUIM SAPeru2 active DMF GMP on record
• MSN PHARMACHEM PRIVATE LTDIndia2 active DMF
• ZAKLADY FARMACEUTYCZNE POLPHARMA SA2 active DMF
• MATRIX PHARMACORP PRIVATE LTDIndia2 active DMF
• APITORIA PHARMA PRIVATE LTDIndia2 active DMF GMP on record
• Neuland Laboratories LimitedIndia2 active DMF
• Alembic Pharmaceuticals LimitedIndia2 active DMF GMP on record
• TAI HENG INDUSTRY CO LTD1 active DMF
• Cadila Pharmaceuticals LimitedIndia1 active DMF GMP on record
• SMS Pharmaceuticals limitedIndia1 active DMF GMP on record
• Suven Life Sciences LimitedIndia1 active DMF
• ERREGIERRE SPAItaly1 active DMF GMP on record
• CAMBREX CHARLES CITY INCUnited States1 active DMF
• JUBILANT BIOSYS LTDIndia1 active DMF
• OLON SPAItaly1 active DMF GMP on record
• TAPI NL BVNetherlands1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• Apotex Inc.Canada1 active DMF
• Alkem Laboratories LimitedIndia1 active DMF GMP on record
• TOPHARMAN SHANDONG CO LTDChina1 active DMF
• INDOCO REMEDIES LTDIndia1 active DMF GMP on record
• GLAND PHARMA LTDIndia1 active DMF GMP on record
• REYOUNG CORPORATION1 active DMF
• Qilu Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• QILU PHARMACEUTICAL CO LTD (LAOLING SITE)1 active DMF

Showing 25 of 45 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (117 approved US products), the latest listed US patent on Aripiprazole expires 15 Dec 2041. Generic API sourcing typically opens up once these lapse.

Therapeutic areas